[Congressional Record Volume 156, Number 117 (Wednesday, August 4, 2010)]
[Senate]
[Pages S6738-S6739]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
By Mrs. MURRAY (for herself and Mr. Crapo):
S. 3703. A bill to expand the research, prevention, and awareness
activities of the Centers for Disease Control and Prevention and the
National Institutes of Health with respect to pulmonary fibrosis, and
for other purposes; to the Committee on Health, Education, Labor, and
Pensions.
Mrs. MURRAY. Mr. President, I am pleased to introduce the Pulmonary
Fibrosis Research Enhancement Act. Even though pulmonary fibrosis, or
PF, kills almost as many people as breast cancer every year, it has not
received the attention it deserves.
Imagine being told by a doctor that you have a life-threatening
disease with no known cure, no consistent standard of care, and no
reliable prognosis. Though environmental factors, including
occupational exposure to pollutants, are believed to play a role in its
onset, PF has no strong demographic profile. In most cases, the doctor
can't even tell you what has caused you to get sick. That is exactly
the situation faced by the 48,000 people who are diagnosed with PF
every year in the United States.
Pulmonary fibrosis attacks the lungs, causing them to stiffen,
thicken, and scar. As the disease progresses, it becomes harder and
harder for oxygen to enter the bloodstream to feed the brain and other
vital organs. Currently, the median survival rate for a person with PF
is only around three years, and the disease kills roughly 40,000 people
every year in the United States. That translates into someone with PF
dying every 13 minutes.
Perhaps the core obstacle in the fight against PF is how shockingly
little we know about the disease. Because the research on PF is still
in its infancy and awareness of PF is less than it needs to be, more
than half of the cases are initially misdiagnosed. The Pulmonary
Fibrosis Research Enhancement Act will start shedding light on PF so
that researchers and doctors can start to figure out how to treat it
effectively. This bill will also make sure health care professionals
have the information they need to make accurate diagnoses of their
patients, catching PF in the early stages and allowing for earlier
treatment.
The Pulmonary Fibrosis Research Enhancement Act will do two major
things to bolster efforts against this disease.
First, the act will establish the National Pulmonary Fibrosis
Advisory Board. The Advisory Board is charged with consulting with and
advising the Director of the Centers for Disease Control to create a
National Pulmonary Fibrosis Action Plan and with presenting the plan to
Congress within one year of the bill's passage. Members
[[Page S6739]]
of this Advisory Board will come from government agencies, volunteer
health organizations, patients and patient advocates, and leading
scientists.
Second, the act will create the first National PF Registry to gather
the data about PF prevalence, risk factors, and development that will
help scientists make progress against this disease. This registry will
allow researchers to see where those diagnosed with PF are located,
which can help determine if there clusters of cases and shed light on
any environmental factors. This registry will also be made available to
all researchers, including the National Institutes of Health and the
Department of Veterans Affairs, and will allow researchers to build on
each others' work to develop treatments in a more streamlined and well-
informed manner.
PF attacks Americans in all walks of life it knows no boundaries and
can affect anyone. The prevalence of PF has increased more than 150
percent since 2001, and is expected to continue rising as the
population of the United States ages. With that in mind, it is clearly
time for Congress to take this first, long overdue step in the battle
against PF. I urge my colleagues to support this bill so we can begin
to bring relief to the hundreds of thousands of Americans who suffer
from PF.
____________________